FDA approves Allergan Weight-Loss Lap-Band for more patients

The FDA approved lower BMI requirements for the LapBand System.FDA broadened the indication on Allergan’s Lap-Band to include obese adults with a body mass index (BMI) of 30 to 40 and at least one obesity-related comorbid condition, such as diabetes, heart disease and gallstones. The expanded indication brings an estimated 37 million Americans into eligibility…… Continue reading FDA approves Allergan Weight-Loss Lap-Band for more patients